Health Line Tearaway Introducer
Health Line International Corporation · Decision date Jun 22, 2026
What did the FDA decide?
FDA records K261950 as a 510(k) premarket notification, with a decision dated Jun 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 22, 2026
Regulatory record facts
- Identifier
- K261950
- Regulatory pathway
- 510(k) premarket notification
- Product code
- DYB
- Decision code
- SESE
- Decision date
- Jun 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Introducer, Catheter.
- Product code
- DYB
- FDA device class
- 2
FDA decision timeline
K261950 received
Application receipt date recorded by FDA.
K261950 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DYB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Giranel Guiding Sheath SetK262674 | Kossel Medtech (Suzhou) Co., Ltd. | 510(k) clearance | Oct 15, 2026 | FDA |
NAMIC Dilator and SheathK253526 | Medline Industries, LP | 510(k) clearance | Jul 29, 2026 | FDA |
| Hartman Medical Group, LLC | 510(k) clearance | Jul 6, 2026 | FDA | |
SimplGuideK261242 | Pendracare | 510(k) clearance | Jun 25, 2026 | FDA |
FieldFlex Steerable SheathK261492 | CenterPoint Systems, LLC | 510(k) clearance | Jun 5, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Health Line International Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Salt Lake City, UT
Sources and methodology
- Original FDA record: K261950
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



